A detailed history of True North Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, True North Advisors, LLC holds 5,080 shares of NVO stock, worth $521,360. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,080
Previous 4,855 4.63%
Holding current value
$521,360
Previous $693,000 12.84%
% of portfolio
0.16%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$119.07 - $145.42 $26,790 - $32,719
225 Added 4.63%
5,080 $604,000
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $32,518 - $38,931
-265 Reduced 5.18%
4,855 $693,000
Q4 2023

Jan 22, 2024

BUY
$87.78 - $105.45 $155,370 - $186,646
1,770 Added 52.84%
5,120 $529,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $71,842 - $157,636
790 Added 30.86%
3,350 $304,000
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $399,308 - $441,984
2,560 New
2,560 $414,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track True North Advisors, LLC Portfolio

Follow True North Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.